Applying transcriptomics or advanced immunohistochemistry along the esophageal epithelium (from normal mucosa through Barrett’s metaplasia to carcinoma) could map which cell types express ITLN1 and how this varies with disease stage [46]. This evidence concerns the gene ITLN1 and Barrett esophagus.